The role of interferon epsilon in ovarian cancer [ 1/1/2021 - 12/31/2025 ]

Research Grant

Brief description Ovarian cancer is difficult to diagnose, patients present at a late stage of disease and it responds poorly to therapy. To improve treatment, it is crucial to gain new insights into ovarian cancer biology. We discovered a new protein, interferon epsilon, which is produced naturally by cells lining the female reproductive tract where it protects against infections and may even prevent development of cancers. We plan to characterise the action of IFNe on HGSOC and how best to use it for therapy.

Funding Amount $1,108,015

Funding Scheme Ideas Grants

Chief Investigator Prof Paul Hertzog

Notes Ideas Grants